T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Catherine Riou, Sharon Madzorera et al.|Nature|2022Cited by 623
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against OmicronRoanne Keeton, Catherine Riou, Marius B. Tincho et al.|medRxiv|2021Cited by 72
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Catherine Riou, Marius B. Tincho et al.|Nature|2022Cited by 22
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Jinal N. Bhiman et al.|PLOS Global Public Health|2024Cited by 12
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Jinal N. Bhiman et al.|medRxiv|2023Cited by 5